Connection

EDWARD MASON to Pneumococcal Infections

This is a "connection" page, showing publications EDWARD MASON has written about Pneumococcal Infections.
Connection Strength

5.246
  1. Increase in prevalence of Streptococcus pneumoniae serotype 6C at Eight Children's Hospitals in the United States from 1993 to 2009. J Clin Microbiol. 2011 Jun; 49(6):2097-101.
    View in: PubMed
    Score: 0.301
  2. Serotype 19A Is the most common serotype causing invasive pneumococcal infections in children. Pediatrics. 2010 Mar; 125(3):429-36.
    View in: PubMed
    Score: 0.279
  3. Molecular epidemiology of pediatric pneumococcal empyema from 2001 to 2007 in Utah. J Clin Microbiol. 2010 Feb; 48(2):520-5.
    View in: PubMed
    Score: 0.275
  4. Recurrent systemic pneumococcal disease in children. Pediatr Infect Dis J. 2007 Jun; 26(6):480-4.
    View in: PubMed
    Score: 0.231
  5. Impact of the pneumococcal conjugate vaccine on pneumococcal parapneumonic empyema. Pediatr Infect Dis J. 2006 Mar; 25(3):250-4.
    View in: PubMed
    Score: 0.212
  6. Penicillin resistance and serotypes/serogroups of Streptococcus pneumoniae in nasopharyngeal carrier children younger than 2 years in Lima, Peru. Diagn Microbiol Infect Dis. 2005 May; 52(1):59-64.
    View in: PubMed
    Score: 0.200
  7. Impact of the conjugate pneumococcal vaccine in arkansas. Pediatr Infect Dis J. 2004 Dec; 23(12):1125-9.
    View in: PubMed
    Score: 0.194
  8. Incidence of invasive pneumococcal disease in children 3 to 36 months of age at a tertiary care pediatric center 2 years after licensure of the pneumococcal conjugate vaccine. Pediatrics. 2003 Apr; 111(4 Pt 1):896-9.
    View in: PubMed
    Score: 0.173
  9. Mechanisms of pneumococcal antibiotic resistance and treatment of pneumococcal infections in 2002. Pediatr Ann. 2002 Apr; 31(4):250-60.
    View in: PubMed
    Score: 0.161
  10. Pneumococcal mastoiditis in children. Pediatrics. 2000 Oct; 106(4):695-9.
    View in: PubMed
    Score: 0.146
  11. Streptococcus pneumoniae in the USA: in vitro susceptibility and pharmacodynamic analysis. J Antimicrob Chemother. 2000 May; 45(5):623-31.
    View in: PubMed
    Score: 0.141
  12. Management of infections due to antibiotic-resistant Streptococcus pneumoniae. Clin Microbiol Rev. 1998 Oct; 11(4):628-44.
    View in: PubMed
    Score: 0.127
  13. Invasive Pneumococcal Disease in Infants Aged 0-60 Days in the United States in the 13-Valent Pneumococcal Conjugate Vaccine Era. J Pediatric Infect Dis Soc. 2018 Aug 17; 7(3):249-252.
    View in: PubMed
    Score: 0.126
  14. Osteoarticular Infections Caused by Streptococcus pneumoniae in Children in the Post-Pneumococcal Conjugate Vaccine Era. Pediatr Infect Dis J. 2017 Dec; 36(12):1201-1204.
    View in: PubMed
    Score: 0.120
  15. Pneumococcal Pneumonia Requiring Hospitalization in US Children in the 13-Valent Pneumococcal Conjugate Vaccine Era. Clin Infect Dis. 2017 Jun 15; 64(12):1699-1704.
    View in: PubMed
    Score: 0.116
  16. Invasive pneumococcal infections in children following transplantation in the pneumococcal conjugate vaccine era. Transpl Infect Dis. 2017 Feb; 19(1).
    View in: PubMed
    Score: 0.112
  17. Emergence of Multidrug-Resistant Pneumococcal Serotype 35B among Children in the United States. J Clin Microbiol. 2017 03; 55(3):724-734.
    View in: PubMed
    Score: 0.111
  18. Clinical and Epidemiological Evidence of the Red Queen Hypothesis in Pneumococcal Serotype Dynamics. Clin Infect Dis. 2016 Sep 01; 63(5):619-626.
    View in: PubMed
    Score: 0.108
  19. Early Streptococcus pneumoniae serotype changes in Utah adults after the introduction of PCV13 in children. Vaccine. 2016 Jan 20; 34(4):474-478.
    View in: PubMed
    Score: 0.104
  20. Penicillin-resistant pneumococci in the United States. Pediatr Infect Dis J. 1995 Nov; 14(11):1017-8.
    View in: PubMed
    Score: 0.103
  21. Multicenter surveillance of Streptococcus pneumoniae isolates from middle ear and mastoid cultures in the 13-valent pneumococcal conjugate vaccine era. Clin Infect Dis. 2015 May 01; 60(9):1339-45.
    View in: PubMed
    Score: 0.098
  22. Impact of the 13-valent pneumococcal conjugate vaccine on chronic sinusitis associated with Streptococcus pneumoniae in children. Pediatr Infect Dis J. 2014 Oct; 33(10):1033-6.
    View in: PubMed
    Score: 0.096
  23. Invasive pneumococcal disease in infants younger than 90 days before and after introduction of PCV7. Pediatrics. 2013 Jul; 132(1):e17-24.
    View in: PubMed
    Score: 0.088
  24. Early trends for invasive pneumococcal infections in children after the introduction of the 13-valent pneumococcal conjugate vaccine. Pediatr Infect Dis J. 2013 Mar; 32(3):203-7.
    View in: PubMed
    Score: 0.086
  25. Changes in Streptococcus pneumoniae serotype 19A invasive infections in children from 1993 to 2011. J Clin Microbiol. 2013 Apr; 51(4):1294-7.
    View in: PubMed
    Score: 0.086
  26. Increased rate of isolation of penicillin-resistant Streptococcus pneumoniae in a children's hospital and in vitro susceptibilities to antibiotics of potential therapeutic use. Antimicrob Agents Chemother. 1992 Aug; 36(8):1703-7.
    View in: PubMed
    Score: 0.083
  27. The changing epidemiology of invasive pneumococcal disease at a tertiary children's hospital through the 7-valent pneumococcal conjugate vaccine era: a case for continuous surveillance. Pediatr Infect Dis J. 2012 Mar; 31(3):228-34.
    View in: PubMed
    Score: 0.080
  28. Characterization of nontypeable and atypical Streptococcus pneumoniae pediatric isolates from 1994 to 2010. J Clin Microbiol. 2012 Apr; 50(4):1326-30.
    View in: PubMed
    Score: 0.079
  29. Streptococcus pneumoniae serotypes in Utah adults at the end of the PCV7 era. Vaccine. 2011 Nov 15; 29(49):9123-6.
    View in: PubMed
    Score: 0.078
  30. Epidemiology of Streptococcus pneumoniae-induced hemolytic uremic syndrome in Utah children. Pediatr Infect Dis J. 2010 Aug; 29(8):712-6.
    View in: PubMed
    Score: 0.072
  31. Serotype 19A is the most common Streptococcus pneumoniae isolate in children with chronic sinusitis. Pediatr Infect Dis J. 2009 Sep; 28(9):766-8.
    View in: PubMed
    Score: 0.068
  32. Streptococcus pneumoniae serogroups 15 and 33: an increasing cause of pneumococcal infections in children in the United States after the introduction of the pneumococcal 7-valent conjugate vaccine. Pediatr Infect Dis J. 2006 Apr; 25(4):301-5.
    View in: PubMed
    Score: 0.053
  33. Effectiveness of abbreviated and delayed 7-valent pneumococcal conjugate vaccine dosing regimens. Vaccine. 2006 Mar 24; 24(14):2514-20.
    View in: PubMed
    Score: 0.052
  34. Temporal trends of invasive disease due to Streptococcus pneumoniae among children in the intermountain west: emergence of nonvaccine serogroups. Clin Infect Dis. 2005 Jul 01; 41(1):21-9.
    View in: PubMed
    Score: 0.050
  35. Acute otitis media due to penicillin-nonsusceptible Streptococcus pneumoniae before and after the introduction of the pneumococcal conjugate vaccine. Clin Infect Dis. 2005 Jun 15; 40(12):1738-44.
    View in: PubMed
    Score: 0.050
  36. Azithromycin compared with beta-lactam antibiotic treatment failures in pneumococcal infections of children. Pediatr Infect Dis J. 2004 May; 23(5):399-405.
    View in: PubMed
    Score: 0.047
  37. Pneumococcal endocarditis in children. Clin Infect Dis. 2004 May 01; 38(9):1273-8.
    View in: PubMed
    Score: 0.046
  38. Decrease of invasive pneumococcal infections in children among 8 children's hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine. Pediatrics. 2004 Mar; 113(3 Pt 1):443-9.
    View in: PubMed
    Score: 0.046
  39. Epidemiology of acute otitis media caused by Streptococcus pneumoniae before and after licensure of the 7-valent pneumococcal protein conjugate vaccine. J Infect Dis. 2003 Dec 01; 188(11):1679-84.
    View in: PubMed
    Score: 0.045
  40. Streptococcus pneumoniae infections in the neonate. Pediatrics. 2003 Nov; 112(5):1095-102.
    View in: PubMed
    Score: 0.045
  41. Macrolide resistance among middle ear isolates of Streptococcus pneumoniae observed at eight United States pediatric centers: prevalence of M and MLSB phenotypes. Pediatr Infect Dis J. 2003 Jul; 22(7):623-7.
    View in: PubMed
    Score: 0.044
  42. Multinational study of pneumococcal serotypes causing acute otitis media in children. Pediatr Infect Dis J. 2002 Nov; 21(11):1008-16.
    View in: PubMed
    Score: 0.042
  43. Invasive pneumococcal infections in children with asplenia. Pediatr Infect Dis J. 2002 Apr; 21(4):278-82.
    View in: PubMed
    Score: 0.040
  44. Six year multicenter surveillance of invasive pneumococcal infections in children. Pediatr Infect Dis J. 2002 Feb; 21(2):141-7.
    View in: PubMed
    Score: 0.040
  45. Invasive pneumococcal infections in pediatric cardiac transplant patients. Pediatr Infect Dis J. 2001 Oct; 20(10):946-50.
    View in: PubMed
    Score: 0.039
  46. Pneumococcal infections in children after transplantation. Clin Infect Dis. 2001 Jul 01; 33(1):16-21.
    View in: PubMed
    Score: 0.038
  47. Outcome of invasive infections outside the central nervous system caused by Streptococcus pneumoniae isolates nonsusceptible to ceftriazone in children treated with beta-lactam antibiotics. Pediatr Infect Dis J. 2001 Apr; 20(4):392-6.
    View in: PubMed
    Score: 0.038
  48. Acute otitis media caused by Streptococcus pneumoniae in children's hospitals between 1994 and 1997. Pediatr Infect Dis J. 2001 Jan; 20(1):34-9.
    View in: PubMed
    Score: 0.037
  49. Pneumococcal facial cellulitis in children. Pediatrics. 2000 Nov; 106(5):E61.
    View in: PubMed
    Score: 0.037
  50. In vitro activities of the oxazolidinone compounds linezolid (PNU-100766) and eperzolid (PNU-100592) against middle ear isolates of Streptococcus pneumoniae. Int J Antimicrob Agents. 1999 Jul; 12(2):141-4.
    View in: PubMed
    Score: 0.033
  51. Three-year multicenter surveillance of systemic pneumococcal infections in children. Pediatrics. 1998 Sep; 102(3 Pt 1):538-45.
    View in: PubMed
    Score: 0.031
  52. Invasive Serotype 35B Pneumococci Including an Expanding Serotype Switch Lineage. Emerg Infect Dis. 2018 02; 24(2):405.
    View in: PubMed
    Score: 0.030
  53. Discrepancies between results by E-test and standard microbroth dilution testing of Streptococcus pneumoniae for susceptibility to vancomycin. J Clin Microbiol. 1996 Jun; 34(6):1546-7.
    View in: PubMed
    Score: 0.027
  54. Penicillin-resistant systemic pneumococcal infections in children: a retrospective case-control study. Pediatrics. 1993 Dec; 92(6):761-7.
    View in: PubMed
    Score: 0.023
  55. Factors associated with middle ear isolates of Streptococcus pneumoniae resistant to penicillin in a children's hospital. J Pediatr. 1991 Dec; 119(6):941-4.
    View in: PubMed
    Score: 0.020
  56. Pneumococcal mastoiditis in children and the emergence of multidrug-resistant serotype 19A isolates. Pediatrics. 2008 Jul; 122(1):34-9.
    View in: PubMed
    Score: 0.016
  57. Maternal immunization with pneumococcal polysaccharide vaccine in the third trimester of gestation. Vaccine. 2001 Dec 12; 20(5-6):826-37.
    View in: PubMed
    Score: 0.010
  58. Antimicrobial activities of beta-lactam antibiotics and gentamicin against penicillin-susceptible and penicillin-resistant pneumococci. Antimicrob Agents Chemother. 1995 May; 39(5):1166-8.
    View in: PubMed
    Score: 0.006
  59. Comparison of E test with standard broth microdilution for determining antibiotic susceptibilities of penicillin-resistant strains of Streptococcus pneumoniae. J Clin Microbiol. 1994 Feb; 32(2):430-2.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.